Pneumococcal Vaccine Research Study

Now enrolling adults 50+

About This Research Study

Pneumococcal disease is caused by bacteria that can infect different parts of the body and is a leading cause of serious illness in people of all ages. Pneumococcal disease is spread from person to person through coughing, sneezing, and close contact. Tekton Research is now enrolling participants in a clinical study evaluating a pneumococcal vaccine for adults 50 years and older with no prior pneumococcal vaccination. Qualified participants may be compensated up to $1,150 for time and travel.

Eligible participants…

  • Must be 50 years and older 
  • Must have not had a prior pneumococcal vaccine
  • May receive compensation for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Tekton enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you

Check Your Eligibility

Study Location(s)

Austin, Texas | Dedicated Research Center

4534 West Gate Blvd #110, Austin, TX 78745

Fort Collins, Colorado | General Medicine Research Site

2126 Milestone Dr. Ste 101, Fort Collins, CO 80525

About Tekton Research

15,000+ people have joined a research study at Tekton

Tekton has been doing research for nearly 20 years

Every study is led by licensed healthcare professionals

"Absolutely professional, courteous, efficient, and a great experience from start to finish. I was totally impressed with the entire crew!!"

Don

Clinical Trial Participant